Chevy Chase Trust Holdings, Inc. Biogen Inc. Transaction History
Chevy Chase Trust Holdings, Inc.
- $32.3 Billion
- Q4 2024
A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 76,820 shares of BIIB stock, worth $11.1 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
76,820
Previous 78,625
2.3%
Holding current value
$11.1 Million
Previous $15.2 Million
22.92%
% of portfolio
0.04%
Previous 0.05%
Shares
31 transactions
Others Institutions Holding BIIB
# of Institutions
998Shares Held
130MCall Options Held
1.12MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.4 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.35 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.09 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.06 Billion0.06% of portfolio
-
Jpmorgan Chase & CO New York, NY5.26MShares$757 Million0.08% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20.7B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...